FSD-201FSD Pharma Inc., a specialty, biotech pharmaceutical R&D company, focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid system of the human body, has received permission from the FDA to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19.